Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Proton Bio
company
About
Proton Bio is mainly engaged in gene and cell therapy CDMO service provider, focusing on the field of gene and cell therapy.
- 251 - 500
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥520M
- Industries
- Biopharma,Biotechnology,Medical
- Founded date
- Jan 1, 2018
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥520M
Proton Bio has raised a total of
¥520M
in funding over 2 rounds. Their latest funding was raised on
Aug 19, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 19, 2022 | Series B | ¥520M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Proton Bio is funded by 2 investors.
China Merchants Securities
and Huatai Health Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
China Merchants Securities
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
